PROVECTUS BIOPHARMACEUTICALS, INC. Stock-Based Compensation
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Stock-Based Compensation of $612.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $305.94K, a 5.01% decline year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $306.05K, a 2.87% decline year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $287.60K.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $312.77K.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.24M, a 3.38% decline from fiscal 2024.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.28M, a 44839.51% increase from fiscal 2023.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $2.85K, a 5.79% decline from fiscal 2022.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $3.02K, a 87.23% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $305.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $612.00K 10-Q · filed 2026-08-13 | $899.60K derived: sum of 3 quarters · filed 2026-08-13 | $1.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $306.05K 10-Q · filed 2026-05-14 | $593.65K derived: sum of 2 quarters · filed 2026-05-14 | $906.43K derived: sum of 3 quarters · filed 2026-05-14 | $1.23M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $287.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $600.38K derived: sum of 2 quarters · filed 2026-03-26 | $922.45K derived: sum of 3 quarters · filed 2026-08-13 | $1.24M 10-K · filed 2026-03-26 |
| 2025-09-30 | $312.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $634.85K derived: sum of 2 quarters · filed 2026-08-13 | $949.95K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $322.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $637.17K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $315.10K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $1.28M 10-K · filed 2026-03-26 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.85K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $2.85K 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.02K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $3.02K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.77K derived: sum of 2 quarters · filed 2023-03-30 | $3.94K derived: sum of 3 quarters · filed 2023-03-30 | $23.69K 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.94K derived: sum of 2 quarters · filed 2022-11-09 | $23.69K 10-Q · filed 2022-11-09 | $153.61K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $21.91K 10-Q · filed 2022-08-11 | $151.84K derived: sum of 3 quarters · filed 2022-08-11 | $155.52K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $19.75K 10-Q · filed 2022-05-12 | $149.68K derived: sum of 2 quarters · filed 2022-05-12 | $153.35K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $129.93K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $133.60K derived: sum of 2 quarters · filed 2022-03-29 | $134.75K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $3.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.83K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.15K 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $1.24K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $3.90K derived: sum of 2 quarters · filed 2021-03-02 | $20.33K derived: sum of 3 quarters · filed 2021-03-02 | $22.98K 10-K · filed 2021-03-02 |
| 2019-09-30 | $2.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $19.09K derived: sum of 2 quarters · filed 2020-11-12 | $21.74K 10-Q · filed 2020-11-12 | $21.74K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $16.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $19.07K 10-Q · filed 2020-08-12 | $19.07K derived: sum of 3 quarters · filed 2020-08-12 | $19.07K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $2.65K 10-Q · filed 2020-05-13 | $2.65K derived: sum of 2 quarters · filed 2020-05-13 | $2.65K derived: sum of 3 quarters · filed 2020-05-13 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $80.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $80.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $80.00K 10-Q · filed 2019-08-08 |